Fuji Chemical Industry Co., Ltd. engages in the synthesis and manufacture of pharmaceutical, food additives, and nutraceutical products. It offers inorganic products for antacids and excipient applications; fast-dissolving oral tablets; and organic products for antispasmodic, anticancer drug, and topical anesthetic applications. In addition, the company provides contract manufacturing services, such as refining APIs, developing new products, powderizing inorganic pharmaceutical products by open and closed spray drying, super-cryogenic temperature reactions, and high-temperature and hydrogenating reactions. It sells its products in Japan, the United States, France, Denmark, Indonesia, Taiwan R.O.C., Spain, the United Kingdom, Thailand, and Korea. The company was founded in 1946 and is headquartered in Nakaniikawa-gun, Japan with additional offices in Tokyo and Osaka, Japan.